NeurologyLive® Brain Games: March 30, 2025
Fremanezumab Reduces Acute Medication Use and Migraine Symptoms in Episodic Migraine, Phase 2b/3 Trial Shows
HEALEY-ALS Platform Trial Amended, WVE-N531 Improves Muscle Growth in DMD, Diazoxide Choline Approved for Prader-Willi Syndrome
NeurologyLive® Friday 5 — March 28, 2025